Long-term clinical outcomes after fetal cell transplantation in parkinson disease: implications for the future of cell therapy

Bega, Danny; Krainc, Dimitri
February 2014
JAMA: Journal of the American Medical Association;2/12/2014, Vol. 311 Issue 6, p617
Academic Journal
journal article
IMPORTANCE: Recent advances in stem cell technologies have rekindled an interest in the use of cell replacement strategies for patients with Parkinson disease. This study reports the very long-term clinical outcomes of fetal cell transplantation in 2 patients with Parkinson disease. Such long-term follow-up data can usefully inform on the potential efficacy of this approach, as well as the design of trials for its further evaluation. OBSERVATIONS: Two patients received intrastriatal grafts of human fetal ventral mesencephalic tissue, rich in dopaminergic neuroblasts, as restorative treatment for their Parkinson disease. To evaluate the very long-term efficacy of the grafts, clinical assessments were performed 18 and 15 years posttransplantation. Motor improvements gained, gradually over the first postoperative years were sustained up to 18 years posttransplantation, while both patients have discontinued, and remained free of any, pharmacological dopaminergic therapy. CONCLUSIONS AND RELEVANCE: The results from these 2 cases indicate that dopaminergic cell transplantation can offer very long-term symptomatic relief in patients with Parkinson disease and provide proof-of-concept support for future clinical trials using fetal or stem cell therapies.


Related Articles

  • Stem cell progress. Coghlan, Andy // New Scientist;1/28/2012, Vol. 213 Issue 2849, p7 

    The article discusses a report published in "The Lancet" by scientist Robert Lanza and colleagues that found that the vision of patients with retinal degradation improved after treatment with an injection of human embryonic stem cells.

  • THERAPEUTIC USE OF HUMAN EMBRYONIC STEM CELLS. Aznar, Justo; Navarro-Illana, Pedro // Acta Bioéthica;2014, Vol. 20 Issue 2, p291 

    No abstract available.

  • Transplantation of hESC-derived hepatocytes protects mice from liver injury. Tolosa, Laia; Caron, Jérôme; Hannoun, Zara; Antoni, Marc; López, Silvia; Burks, Deborah; Vicente, Jose; Weber, Anne; Gomez-Lechon, Maria-Jose; Dubart-Kupperschmitt, Anne // Stem Cell Research & Therapy;12/12/2015, Vol. 6, p1 

    Background: Hepatic cell therapy has become a viable alternative to liver transplantation for life-threatening liver diseases. However, the supply of human hepatocytes is limited due to the shortage of suitable donor organs required to isolate high-quality cells. Human pluripotent stem cells...

  • Direct Reprogramming. Marbán, Eduardo; Cingolani, Eugenio // JAMA: Journal of the American Medical Association;7/7/2015, Vol. 314 Issue 1, p19 

    The authors comment on the direct reprogramming of stem cells for therapeutics. Topics covered include concerns that have restricted in vivo applications of tissues and organs to be recreated from embryonic stem cells, the limitations of induced stem cells as well as the complexity of...

  • Funding windfall rescues abandoned stem-cell trial. Check Hayden, Erika // Nature;6/1/2014, Vol. 510 Issue 7503, p18 

    The article discusses trial on human embryonic stem cells started in California whether it can helpful in regrowing nerves in spinal-cord injury, and mentions challenges in this trial. It mentions Asterias Biotherapeutics Inc. located at Menlo Park, California started trial with 14.3 million...

  • Stem Cells Able to Form Optic Cup.  // Review of Ophthalmology;Jul2012, Vol. 19 Issue 7, p6 

    The article discusses the study by Yoshiki Sasai on the use human-derived stem cell or human embryonic stem cells (hESCs), which is able to form an optic cup.

  • A Retrospective of the Stem Cell Debate. Cook, Michael // Australasian Science;Jul/Aug2013, Vol. 34 Issue 6, p48 

    The article focuses on a debate pertaining to stem cell therapy. Proponents say that embryonic stem cell therapy would result in cures for Parkinson's and Alzheimer's. Opponents cite the morality behind the use of embryos, which they consider as having human likeness. Stem cell research faltered...

  • Parkinson's Disease Update.  // PharmaWatch: CNS;Aug2007, Vol. 6 Issue 8, p8 

    The article offers world news briefs related to pharmaceutical industries that develop drugs for Parkinson's disease treatment. Israeli biotechnology company Pluristem Life Systems states that its placenta-derived stem cell therapy has demonstrated potential to treat Parkinson's disease. Titan...

  • INTRODUCTION: THE IMPACT OF CONTINUOUS LEVODOPA INFUSION IN THE TREATMENT OF PARKINSON'S DISEASE. Wolters, Erik // CNS Spectrums: The International Journal of Neuropsychiatric Med;April2008 Supplement 7, Vol. 13 Issue 4, p3 

    The article introduces various reports published within the issue including an article on the importance of steady-state blood L-dopa levels to reduce motor complications and an article about treatment strategies for Parkinson's disease that employ continuous dopaminergic stimulation.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics